Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Opalka

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Journal of the Neurological Sciences|May 1, 1993
Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissueW Liedtke, B Opalka, C W Zimmermann, et al.
PCR Methods and Applications|April 1, 1994
Different methods of sample preparation influence sensitivity of Mycobacterium tuberculosis and Borrelia burgdorferi PCRW Liedtke, B Opalka, C W Zimmermann, et al.
Haematology and Blood Transfusion|January 1, 1989
Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigationsB Opalka, O Kloke, U Wandl, et al.
European Journal of Immunology|July 1, 1983
Characterization of the cytolytic activity of a cloned antigen-specific T suppressor cell derived from a tolerant CBA/J mouseJ Heuer, B Opalka, J Rassat, et al.
Intervirology|January 1, 1994
Altered host range phenotype of the transformation-defective Ad12 mutant CS-1 is due to deletions in the E1 regionB Opalka, M Reith-Witowski, H C Kirch, et al.
Cancer Research|August 5, 2000
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agentsT Stiewe, K Parssanedjad, H Esche, et al.
Intervirology|January 1, 1989
Genome structure of adenovirus 12 host range mutants adapted to growth in simian Vero cellsE Salewski, G Werner, B Opalka, et al.
Leukemia|June 1, 1991
Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapyB Opalka, U Wandl, U Beer, et al.
Genomics|July 1, 1997
Yeast artificial chromosome transfer into human renal carcinoma cells by spheroplast fusionK Jülicher, L Vieten, F Bröcker, et al.
Arthritis and Rheumatism|March 1, 1996
Limited heterogeneity of rearranged T cell receptor V alpha and V beta transcripts in synovial fluid T cells in early stages of rheumatoid arthritisD C Fischer, B Opalka, A Hoffmann, et al.
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Journal of the Neurological Sciences|May 1, 1993
Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissueW Liedtke, B Opalka, C W Zimmermann, et al.
PCR Methods and Applications|April 1, 1994
Different methods of sample preparation influence sensitivity of Mycobacterium tuberculosis and Borrelia burgdorferi PCRW Liedtke, B Opalka, C W Zimmermann, et al.
Haematology and Blood Transfusion|January 1, 1989
Treatment of chronic myelogenous leukemia with interferons: hematologic, cellular, and genetic investigationsB Opalka, O Kloke, U Wandl, et al.
European Journal of Immunology|July 1, 1983
Characterization of the cytolytic activity of a cloned antigen-specific T suppressor cell derived from a tolerant CBA/J mouseJ Heuer, B Opalka, J Rassat, et al.
Intervirology|January 1, 1994
Altered host range phenotype of the transformation-defective Ad12 mutant CS-1 is due to deletions in the E1 regionB Opalka, M Reith-Witowski, H C Kirch, et al.
Cancer Research|August 5, 2000
E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agentsT Stiewe, K Parssanedjad, H Esche, et al.
Intervirology|January 1, 1989
Genome structure of adenovirus 12 host range mutants adapted to growth in simian Vero cellsE Salewski, G Werner, B Opalka, et al.
Leukemia|June 1, 1991
Breakpoint localization within the M-bcr and clinical course do not correlate in patients with chronic myelogenous leukemia undergoing alfa interferon therapyB Opalka, U Wandl, U Beer, et al.
Genomics|July 1, 1997
Yeast artificial chromosome transfer into human renal carcinoma cells by spheroplast fusionK Jülicher, L Vieten, F Bröcker, et al.
Arthritis and Rheumatism|March 1, 1996
Limited heterogeneity of rearranged T cell receptor V alpha and V beta transcripts in synovial fluid T cells in early stages of rheumatoid arthritisD C Fischer, B Opalka, A Hoffmann, et al.
Pageof 7